PGNY Progyny

Progyny, Inc. Promotes Seasoned Executive Mark Livingston to Chief Financial Officer

Progyny, Inc. Promotes Seasoned Executive Mark Livingston to Chief Financial Officer

Livingston Will Continue Reporting to Pete Anevski, Progyny’s President and Chief Operating Officer

NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that Mark Livingston, Progyny’s Executive Vice President of Finance, has been promoted to Chief Financial Officer, effective as of September 15, 2020. In this expanded role, Mr. Livingston will continue to report to Pete Anevski, Progyny’s President and Chief Operating Officer. Mr. Anevski had also been Progyny’s CFO since 2017.

Mr. Livingston, 54, joined Progyny in 2019, bringing more than 30 years of experience in accounting, public company reporting, and financial planning and analysis at leading healthcare, technology and media companies. He has previously served as CFO of the international business at Scripps Network Interactive and as CFO at Emerson, Reid & Company, an employee benefits wholesaler. Mr. Livingston has also held senior financial leadership roles at WebMD and Hess Corporation.

“I have known and worked with Mark for over 20 years. He is an exceptional leader who played a critical role both in ensuring Progyny’s readiness to become a public company as well as our continued success following the offering, and I look forward to continue working closely with him in this expanded role,” said Mr. Anevski. “Progyny is in the earliest stages of addressing its significant market opportunities. With Mark now leading our financial operations, I am able to increase my focus on scaling the business for continued growth and executing our long-term strategic vision.”

“When Mark joined Progyny, we looked to him to broaden and enhance the capabilities of our finance and accounting functions, and through his energy, expertise and insight, he has helped extend Progyny’s leadership position in the market,” said David Schlanger, Chief Executive Officer of Progyny. “We couldn’t be more pleased to see him take on a larger role at Progyny and to begin working with the investment community more closely.”

“Progyny is transforming fertility benefits management, providing a better experience and achieving optimal outcomes for patients, employers and physicians,” said Mr. Livingston. “This is an incredibly exciting time for the company, and I look forward to addressing our substantial market opportunities.”  

Mr. Livingston received his bachelor's degree in Management and Accounting from Tulane University and is a licensed Certified Public Accountant.

About Progyny

Progyny (Nasdaq: PGNY) is a leading fertility benefits management company in the US. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously benefit employers, patients, and physicians.  

Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so. 

Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit .

For Further Information, Please Contact:

Investors:

James Hart

Media:

Selena Yang

EN
09/09/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Progyny

 PRESS RELEASE

Progyny, Inc. Executives to Participate in Upcoming Investor Conferenc...

Progyny, Inc. Executives to Participate in Upcoming Investor Conferences NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that several members of its leadership team will participate in upcoming investor conferences in March, including the Leerink Partners Global Healthcare Conference, the Barclays Global Healthcare Conference, and the KeyBanc Capital Markets Healthcare Forum. At the Leerink Partners Global Healthcare Conference, Mark Livingston, Chief Financial Officer, will partic...

 PRESS RELEASE

Progyny, Inc. Announces Fourth Quarter 2025 Results

Progyny, Inc. Announces Fourth Quarter 2025 Results Reports Revenue of $318.4 Million, Reflecting Fourth Quarter Growth of 6.7% and 10% for the Full YearGenerated Record $210.2 Million in Full Year Operating Cash FlowReturned Value to Shareholders Through Repurchase of Approximately 6.5 Million Shares To Date Under Recent AuthorizationIssues Financial Guidance for 2026, Reflecting Tenth Consecutive Year of Revenue Growth NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women's health and family building solutions, t...

 PRESS RELEASE

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2...

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period and full year ended December 31, 2025, after the close of the market on Thursday, February 26, 2026. The company will host a conference call at 4:45 p.m. Eastern Time (1:45 p.m. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants ...

 PRESS RELEASE

Progyny to Discuss Updated Financial Expectations at Upcoming JP Morga...

Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference Anticipates Fourth Quarter and Full Year Results to Be Slightly Above Previously Provided Financial Guidance NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women’s health and family building solutions, today announced that the Company is participating in the 44th Annual JP Morgan Healthcare Conference, where it intends to discuss its updated expectations for the quarter and year ending December 31, 2025. “As the fourth quarter progr...

 PRESS RELEASE

New Men’s Health Research from Progyny Challenges Conventional Beliefs...

New Men’s Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action 75% of men see fertility as an equal gender topic and acknowledge the connection between fertility health and their overall health, yet only 46% of men with a fertility issue have sought support due to stigma, cost, and other barriers. NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: PGNY), a global leader in family building solutions, today announced exploring experiences and views on fertility. The findings shed light on how men in the U.S. view their role in the fertilit...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch